791
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Identification of HPV16-p16INK4a mediated methylation in oral potentially malignant disorder

, ORCID Icon & ORCID Icon
Pages 1016-1030 | Received 18 Jun 2020, Accepted 29 Sep 2020, Published online: 09 Nov 2020

References

  • Sarode SC, Sarode GS, Karmarkar S, et al. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol. 2011;47(9):920–921.
  • Perdomo-Lara SJ, Buenahora MR, Álvarez E, et al. Human papilloma virus genotypes in dysplasia and epithelial hyperplasia of oral cavity using the luminex xmap technology. A multicenter study. Med Oral Patol Oral Cir Bucal. 2020 1;25:e61–e70. Published 2020 Jan 1. .
  • Ishibashi M, Kishino M, Sato S, et al. The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control. Int J Clin Oncol. 2011;16(6):646–653.
  • Liu W, Wang YF, Zhou HW, et al. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010;10:685. Published 2010 Dec 16. .
  • Du M, Nair R, Jamieson L, et al. Incidence Trends of Lip, Oral Cavity, and Pharyngeal Cancers: Global Burden of Disease 1990-2017. J Dent Res. 2020;99(2):143–151.
  • Jemal A, Bray F, Center MM, et al. Global cancer statistics [published correction appears in CA. 2011 Mar-Apr;61(2):134]. CA Cancer J Clin. 2011;61(2):69–90.
  • Mohideen K, Krithika C, Jeddy N, et al. Meta-analysis on risk factors of squamous cell carcinoma of the tongue in young adults. J Oral Maxillofac Pathol. 2019;23(3):450–457.
  • Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology. 2016;151(5):860–869.e7.
  • Ajila V, Shetty H, Babu S, et al. Human papilloma virus associated squamous cell carcinoma of the head and neck. J Sex Transm Dis. 2015;2015:791024.
  • Zhao YH, Bai YP, Mao ML, et al. Zhonghua Bing Li Xue Za Zhi. 2019;48(2):127–131.
  • Husain N, Neyaz A. Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts. J Oral Biol Craniofac Res. 2017;7(3):198–205.
  • Lindsay C, Seikaly H, Biron VL. Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets. J Otolaryngol Head Neck Surg. 2017;46(1):9. Published 2017 Jan 31. .
  • Torres-Rendon A, Stewart R, Craig GT, et al. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncol. 2009;45(6):468–473.
  • Wils LJ, Poell JB, Evren I, et al. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Mod Pathol. 2020;33(6):1033–1040.
  • William WN Jr, Papadimitrakopoulou V, Lee JJ, et al. Erlotinib and the risk of oral cancer: the Erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial. JAMA Oncol. 2016;2(2):209–216.
  • Banerjee AG, Bhattacharyya I, Vishwanatha JK. Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol Cancer Ther. 2005;4(6):865–875.
  • Németh CG, Röcken C, Siebert R, et al. Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus. PLoS One. 2019;14(4):e0215055. Published 2019 Apr 9
  • Carenzo A, Serafini MS, Roca E, et al. Gene expression clustering and selected head and neck cancer gene signatures highlight risk probability differences in oral premalignant lesions. Cells. 2020;9(8):E1828. Published 2020 Aug 3. .
  • Soto D, Song C, McLaughlin-Drubin ME. Epigenetic alterations in human papillomavirus-associated cancers. Viruses. 2017;9(9):248. Published 2017 Sep 1. .
  • Sartor MA, Dolinoy DC, Jones TR, et al. Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics. 2011;6(6):777–787.
  • van Kempen PM, van Bockel L, Braunius WW, et al. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation. Cancer Med. 2014;3(5):1185–1196.
  • Spector ME, Sacco AG, Bellile E, et al. E6 and E7 antibody levels are potential biomarkers of recurrence in patients with advanced-stage human papillomavirus-positive oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2017;23(11):2723–2729.
  • van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal. 2014;19(4):e386–e390. Published 2014 Jul 1. .
  • Langendijk JA, Psyrri A. The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies. Ann Oncol. 2010;21(10):1931–1934.
  • Grønhøj Larsen C, Gyldenløve M, Jensen DH, et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer. 2014;110(6):1587–1594.
  • Lechner M, Fenton T, West J, et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med. 2013;5(2):15. Published 2013 Feb 5. .
  • Gaździcka J, Gołąbek K, Strzelczyk JK, et al. Epigenetic modifications in head and neck cancer. Biochem Genet. 2020;58(2):213–244.
  • Dvojakovska S, Popovic-Monevska D, Grcev A, et al. Promotor hypermethylated genes: Prospective diagnostic biomarkers in oral cancerogenesis. J Craniomaxillofac Surg. 2018;46(10):1737–1740.
  • Allameh A, Moazeni-Roodi A, Harirchi I, et al. Promoter DNA methylation and mRNA expression level of p16 gene in oral squamous cell carcinoma: correlation with clinicopathological characteristics. Pathol Oncol Res. 2019;25(4):1535–1543.
  • Wu W, Wang Z, Zhou Z. Role of the human papillomavirus in malignant transformation of oral leukoplakia distinct from oropharyngeal squamous cell carcinoma: A study of 76 patients with internal-control specimens. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128(3):273–279.
  • Müller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):591–602.
  • Kostopoulou E, Samara M, Kollia P, et al. Different patterns of p16 immunoreactivity in cervical biopsies: correlation to lesion grade and HPV detection, with a review of the literature. Eur J Gynaecol Oncol. 2011;32(1):54–61.
  • Darragh TM, Colgan TJ, Thomas Cox J, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology [published correction appears in Int J Gynecol Pathol. 2013 Jul;32(4):432][published correction appears in Int J Gynecol Pathol. 2013 Mar;32(2):241]. Int J Gynecol Pathol. 2013;32(1):76–115.
  • Shikova E, Todorova I, Ganchev G, et al. Detection and Typing of Human Papillomaviruses by PCR. Biotechnol Biotechnol Equip. 2009;23(sup1):877–880.
  • Cubie HA, Seagar AL, McGoogan E, et al. Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18 [published correction appears in Mol Pathol 2001 Jun;54(3):200]. Mol Pathol. 2001;54(1):24–29.
  • Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27(11):1571–1572.
  • Cavalcante RG, Sartor MA. annotatr: genomic regions in context. Bioinformatics. 2017;33(15):2381–2383.
  • Degli Esposti D, Sklias A, Lima SC, et al. Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas. Genome Med. 2017;9(1):33. Published 2017 Apr 5. .
  • Fregonesi PA, Teresa DB, Duarte RA, et al. p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem. 2003;51(10):1291–1297.
  • Awange DO, Wakoli KA, Onyango JF, et al. Reactive localised inflammatory hyperplasia of the oral mucosa. East Afr Med J. 2009;86(2):79–82.
  • Tang KD, Menezes L, Baeten K, et al. Oral HPV16 prevalence in oral potentially malignant disorders and oral cavity cancers. Biomolecules. 2020;10(2):223. Published 2020 Feb 3. .
  • Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884–11894.
  • Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545.
  • Jain A. Molecular pathogenesis of oral squamous cell carcinoma, squamous cell carcinoma - hallmark and treatment modalities. Hamid Elia Daaboul: IntechOpen; May 31 2019. DOI:https://doi.org/10.5772/intechopen.85650
  • Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol. 2006;7(1):77–82.
  • Di Domenico M, Giovane G, Kouidhi S, et al. HPV epigenetic mechanisms related to oropharyngeal and cervix cancers. Cancer Biol Ther. 2018;19(10):850–857.
  • Lleras RA, Smith RV, Adrien LR, et al. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin Cancer Res. 2013;19(19):5444–5455.
  • Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12(3 Pt 1):701–709.
  • Tripathi R, Rath G, Jawanjal P, et al. Clinical impact of de-regulated Notch-1 and Notch-3 in the development and progression of HPV-associated different histological subtypes of precancerous and cancerous lesions of human uterine cervix. PLoS One. 2014;9(6):e98642. Published 2014 Jun 6. .
  • Kranjec C, Holleywood C, Libert D, et al. Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch. J Pathol. 2017;242(4):448–462.
  • Dotto GP. Notch tumor suppressor function. Oncogene. 2008;27(38):5115–5123.
  • Agrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333(6046):1154–1157.
  • Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157–1160.
  • Izumchenko E, Sun K, Jones S, et al. Notch1 mutations are drivers of oral tumorigenesis. Cancer Prev Res (Phila). 2015;8(4):277–286.
  • Chen H, Ning X, Jiang Z. Caspases control antiviral innate immunity. Cell Mol Immunol. 2017;14(9):736–747.
  • Moris N, Edri S, Seyres D, et al. Histone acetyltransferase KAT2A stabilizes pluripotency with control of transcriptional heterogeneity. Stem Cells. 2018;36(12):1828–1838.
  • Terhune SS, Moorman NJ, Cristea IM, et al. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. PLoS Pathog. 2010;6(6):e1000965. Published 2010 Jun 24. .
  • Park JJ, Kim YE, Pham HT, et al. Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts. J Gen Virol. 2007;88(Pt 12):3214–3223.
  • Zimmermann H, Degenkolbe R, Bernard HU, et al. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol. 1999;73(8):6209–6219.
  • Gillison ML, Akagi K, Xiao W, et al. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res. 2019;29(1):1–17.
  • Zanier K, Charbonnier S, Sidi AO, et al. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science. 2013;339(6120):694–698.
  • Huh K, Zhou X, Hayakawa H, et al. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol. 2007;81(18):9737–9747.
  • White EA, Sowa ME, Tan MJ, et al. Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc Natl Acad Sci U S A. 2012;109(5):E260–E267.
  • Curry JM, Sprandio J, Cognetti D, et al. Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol. 2014;41(2):217–234.
  • Gupta S, Gupta S. Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literature. Indian J Dent. 2015;6(2):91–98.
  • Zhou H, Miki R, Eeva M, et al. Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. Clin Cancer Res. 2007;13(8):2344–2353.
  • Westrich JA, Warren CJ, Pyeon D. Evasion of host immune defenses by human papillomavirus. Virus Res. 2017;231:21–33.
  • Hasan UA, Zannetti C, Parroche P, et al. The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter. J Exp Med. 2013;210(7):1369–1387.
  • Hong S, Laimins LA. Manipulation of the innate immune response by human papillomaviruses. Virus Res. 2017;231:34–40.
  • Yang H, Lin CH, Ma G, et al. Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J Biol Chem. 2003;278(18):15495–15504.
  • Oldak M, Tolzmann L, Wnorowski A, et al. Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7. J Virol. 2011;85(1):178–188.
  • Nees M, Geoghegan JM, Hyman T, et al. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol. 2001;75(9):4283–4296.
  • Chiang C, Pauli EK, Biryukov J, et al. The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 to suppress RIG-I-mediated innate immune signaling. J Virol. 2018;92(6):e01737–17. Published 2018 Feb 26. .
  • Pyeon D, Pearce SM, Lank SM, et al. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 2009;5(2):e1000318.
  • Yang H, Wu L, Ke S, et al. Downregulation of Ubiquitin-conjugating enzyme UBE2D3 promotes telomere maintenance and radioresistance of Eca-109 human esophageal carcinoma cells. J Cancer. 2016;7(9):1152–1162. Published 2016 Jun 6. .
  • Raza MA, Yu N, Wang D, et al. Differential DNA methylation and gene expression in reciprocal hybrids between Solanum lycopersicum and S. pimpinellifolium. DNA Res. 2017;24(6):597–607.
  • Niesen MI, Osborne AR, Yang H, et al. Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX. J Biol Chem. 2005;280(47):38914–38922.
  • Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41(2):178–186.
  • Mesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe. 2014;15(3):266–282.
  • Hoppe-Seyler K, Bossler F, Braun JA, et al. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 2018;26(2):158–168.
  • Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576–582.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.